A Pilot Multi-Institutional Study to Evaluate the Accuracy of a Breast Cancer Locator in Patients with Palpable Cancers
Our objective is to determine whether the Breast Cancer Locator (BCL) can safely and
effectively localize breast cancers in patients treated at locations distant from the site of
BCL manufacture. This information will be transmitted to CairnSurgical, Inc. where the BCL
will be fabricated, tested for quality assurance, sterilized and shipped to the patient''s
surgeon. The surgeon will then utilize the BCL at the time of resection of the palpable
View more details from ClinicalTrials.gov.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.